Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | CRHBP | P24387 | 1/20 | 0.57 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.57 |
| ▸ | CASP3 | P42574 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 4/20 | 0.51 |
| ▸ | ATM | Q13315 | 2/20 | 0.51 |
| ▸ | RGS12 | O14924 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.45 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29265514 | 0.84 | ALDH1A1 (0.64) | POLBALDH1A1RXFP1MEN1KMT2A | |
| SCHEMBL18691421 | 0.84 | KMT2A (0.74) | POLBALDH1A1RXFP1MEN1KMT2A | |
| SCHEMBL4904889 | 0.84 | DYRK3 (0.59) | POLBALDH1A1RXFP1MEN1KMT2A | |
| SCHEMBL3754061 | 0.84 | FGFR1 (0.58) | POLBALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL18028312 | 0.81 | ALDH1A1 (0.61) | POLBALDH1A1RXFP1MEN1KMT2A | |
| SCHEMBL9280366 | 0.80 | ALDH1A1 (0.58) | POLBALDH1A1RXFP1MEN1KMT2A | |
| SCHEMBL4226951 | 0.80 | KMT2A (0.49) | POLBALDH1A1RXFP1MEN1KMT2A | |
| SCHEMBL4596137 | 0.78 | ALDH1A1 (1.00) | POLBALDH1A1RXFP1MEN1KMT2A | |
| SCHEMBL11042478 | 0.78 | ALDH1A1 (0.70) | POLBALDH1A1RXFP1MEN1KMT2A | |
| SCHEMBL1001022 | 0.78 | ALDH1A1 (0.70) | POLBALDH1A1RXFP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060032294-A1 | Leak detection system for use in braking systems | SPECTRONICS CORPORATION | 2006-02-16 | — | — | US | claimed |
| US-20240224999-A1 | METABOLIC INHIBITORS FOR CONTROLLING BIOFILM | MC US 3 LLC (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240117232-A1 | DROP-IN RECYCLED REFRIGERANT COMPOSITIONS HAVING NO NET GWP BEING A DROP-IN REPLACEMENT FOR R-32 AND R-454B | THE COULAN COMPANY, L.L.C. (US) | 2024-04-11 | — | — | US | disclosed |
| US-11746271-B1 | Drop-in recycled refrigerant compositions having no net GWP | The Coulan Company L.L.C. (US) | 2023-09-05 | — | — | US | disclosed |
| US-20230183640-A1 | METABOLIC INHIBITORS WITH EFFICACY FOR INHIBITING SULFIDE PRODUCTION IN HARSH ENVIRONMENTS | LANXESS CORPORATION | 2023-06-15 | — | — | US | disclosed |
| US-11655407-B1 | Drop-in recycled refrigerant compositions having no net GWP replacing R-410A | THE COULAN COMPANY, L.L.C. (US) | 2023-05-23 | — | — | US | disclosed |
| US-20100058837-A1 | DEVICE HAVING MULTIPLE LIGHT SOURCES AND METHODS OF USE | THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. | 2010-03-11 | — | — | US | disclosed |
| US-7552623-B2 | Enhanced leak detection dye carrier | SPECTRONICS CORPORATION (US) | 2009-06-30 | — | — | US | disclosed |
| US-7528144-B2 | Molecules and methods for fluorescence microscopy | WISYS TECHNOLOGY FOUNDATION, INC. (US) | 2009-05-05 | — | — | US | disclosed |
| US-20080265213-A1 | Enhanced Leak Detection Dye Carrier | SPECTRONICS CORPORATION (US) | 2008-10-30 | — | — | US | disclosed |
| WO-1996007088-A1 | METHOD OF INTRODUCING LEAK DETECTION FLUID | SPECTRONICS CORPORATION (US) | 1996-03-07 | — | — | WO | disclosed |
| US-5420136-A | Eradication of pathogenic biological contaminants using non-azo naphthalimide dyes | MICROBIOMED CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0639080-A4 | — | — | 1995-03-29 | — | — | EP | disclosed |
| EP-0639080-A1 | NON-AZO NAPHTHALIMIDE DYES AND USES FOR SAME | MICROBIOMED CORPORATION (US) | 1995-02-22 | — | — | EP | disclosed |
| WO-1994011726-A1 | NON-AZO 1,8-NAPHTHALIMIDE DYES FOR THE DETECTION AND QUANTITATION OF A PARAMAGNETIC METAL CATION IN A NON-AQUEOUS MEDIUM | MICROBIOMED CORPORATION (US) | 1994-05-26 | — | — | WO | disclosed |
| US-5308773-A | Monitoring engine wear by measuring the fluorescence of the complex formed by mixing the lubricant oil with the fluorescent dye and calibrating the concentration | MICROBIOMED CORP. (US) | 1994-05-03 | — | — | US | disclosed |
| US-5279967-A | Using fluorophore label | NALCO CHEMICAL COMPANY (US) | 1994-01-18 | — | — | US | disclosed |
| US-5279967-A | Using fluorophore label | NALCO CHEMICAL COMPANY (US) | 1994-01-18 | — | — | US | disclosed |
| WO-1993018789-A1 | NON-AZO NAPHTHALIMIDE DYES AND USES FOR SAME | MICROBIOMED CORPORATION (US) | 1993-09-30 | — | — | WO | disclosed |
| US-5235045-A | Viricides | MICROBIOMED CORPORATION (US) | 1993-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240224999-A1 | METABOLIC INHIBITORS FOR CONTROLLING BIOFILM | RIMKLA, HDHD5, SCD | POLB 1222/4885ALDH1A1 1413/4885RXFP1 2993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.